Skip to Primary Navigation

DOL declares final pharmacy benefit manager fee disclosure rule

A photo of 3 prescription drug bottles laying sideways on a table.
Photo: Spencer Platt/Getty Images

Effective July 2027, the rule requires PBMs to disclose rebates and other payments from drug makers, plus payments from pharmacies.

The Department of Labor (DOL) has finalized a new rule requiring pharmacy benefits managers (PBMs) to disclose payment details from drug companies.

Under the final rule, PBMs – which act as intermediaries between drugmakers, pharmacies, and insurers – will be required to disclose rebates and other payments from drug manufacturers,

Get full access, free for a month

This is a Premium article. Start your 28-day free trial to continue reading and access all content on GRIP – no payment details required.

What’s included:

  • Every new article, plus our 5,000+ archive
  • Daily regulatory insight and guidance
  • Exclusive interviews and in-depth analysis
  • Coverage of industry-leading events and conferences
  • All podcasts and videos, featuring industry experts
  • The full set of Rules Navigator tools
  • An ad-free experience